ThoughtSphere, a leading provider of clinical data and analytics solutions, is celebrating its fifth year of delivering AI-enabled efficiencies in clinical trial operations. The company’s platform combines artificial intelligence and machine learning capabilities to enhance the speed and quality of clinical trial processes. Since its inception in 2015, ThoughtSphere has focused on unifying data, people, and processes to accelerate the delivery of clinical trials. The company has developed a suite of fully integrated, AI-enabled solutions that automate tasks and provide valuable data insights. In 2019, ThoughtSphere received a US Patent for its ClinHUB technology, which automates data ingestion and standardization tasks, resulting in significant time and cost savings for customers. ThoughtSphere’s CEO and Founder, Sudeep Pattnaik, stated that the company’s vision was to unify data using AI, and its comprehensive suite of solutions reflects that focus. The platform’s unified data layer allows for seamless integration of modules for various clinical trial tasks, empowering clinical professionals to work more efficiently and eliminating manual processes. By leveraging AI models and surfacing data quicker, ThoughtSphere has enabled its customers to reduce review cycle times and achieve database lock faster. To learn more about ThoughtSphere and its solutions, visit thoughtsphere.com.
ThoughtSphere Marks 5-Year Milestone as Leader in AI-Enabled Clinical Trial Efficiency
Date:
Updated: [falahcoin_post_modified_date]